Lukas Kenner

19.1k total citations · 3 hit papers
225 papers, 10.4k citations indexed

About

Lukas Kenner is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Lukas Kenner has authored 225 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Molecular Biology, 77 papers in Oncology and 43 papers in Immunology. Recurrent topics in Lukas Kenner's work include Cytokine Signaling Pathways and Interactions (28 papers), Lymphoma Diagnosis and Treatment (22 papers) and Prostate Cancer Treatment and Research (17 papers). Lukas Kenner is often cited by papers focused on Cytokine Signaling Pathways and Interactions (28 papers), Lymphoma Diagnosis and Treatment (22 papers) and Prostate Cancer Treatment and Research (17 papers). Lukas Kenner collaborates with scholars based in Austria, Germany and United States. Lukas Kenner's co-authors include Erwin F. Wagner, Robert Eferl, Rainer Zenz, Michaela Schlederer, Harald Scheuch, Richard Moriggl, Martina Rath, Suzanne D. Turner, Erwin Tschachler and Olaf Merkel and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Lukas Kenner

212 papers receiving 10.3k citations

Hit Papers

p62 Is a Common Component... 2002 2026 2010 2018 2002 2015 2023 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Lukas Kenner 5.1k 3.0k 2.2k 1.5k 1.0k 225 10.4k
Hong Zhao 4.7k 0.9× 3.9k 1.3× 2.9k 1.3× 1.7k 1.1× 1.0k 1.0× 273 12.5k
Kevin Shannon 6.2k 1.2× 2.2k 0.7× 1.6k 0.7× 871 0.6× 1.1k 1.1× 276 12.5k
Yi-Xin Zeng 6.8k 1.3× 3.6k 1.2× 1.8k 0.8× 3.8k 2.5× 945 0.9× 183 11.3k
Qian Tao 6.8k 1.3× 3.2k 1.1× 1.0k 0.5× 2.1k 1.4× 860 0.9× 297 11.0k
Rajiv Kumar 5.3k 1.0× 3.2k 1.0× 959 0.4× 2.1k 1.4× 672 0.7× 259 9.6k
Changshun Shao 5.3k 1.0× 2.0k 0.7× 1.9k 0.9× 2.0k 1.3× 606 0.6× 190 9.9k
Manabu Fukumoto 4.3k 0.8× 2.5k 0.8× 1.2k 0.6× 1.6k 1.1× 572 0.6× 319 9.5k
Philip J. Coates 4.5k 0.9× 3.1k 1.0× 1.0k 0.5× 1.3k 0.9× 861 0.9× 205 9.4k
William P. Schiemann 6.8k 1.3× 3.5k 1.2× 1.3k 0.6× 2.4k 1.6× 501 0.5× 132 11.1k
Daniel E. Johnson 8.4k 1.6× 4.3k 1.4× 2.2k 1.0× 2.3k 1.5× 737 0.7× 133 13.6k

Countries citing papers authored by Lukas Kenner

Since Specialization
Citations

This map shows the geographic impact of Lukas Kenner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas Kenner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas Kenner more than expected).

Fields of papers citing papers by Lukas Kenner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lukas Kenner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas Kenner. The network helps show where Lukas Kenner may publish in the future.

Co-authorship network of co-authors of Lukas Kenner

This figure shows the co-authorship network connecting the top 25 collaborators of Lukas Kenner. A scholar is included among the top collaborators of Lukas Kenner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lukas Kenner. Lukas Kenner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fuereder, Thorsten, Agmal Scherzad, Stephan Hackenberg, et al.. (2025). Monotherapy With Immune Checkpoint Inhibitors in Patients With Recurrent and/or Metastatic Sinonasal Squamous Cell Carcinoma. Cancer Medicine. 14(23). e71391–e71391.
2.
Spielvogel, Clemens P., Jing Ning, László Papp, et al.. (2024). Preoperative detection of extraprostatic tumor extension in patients with primary prostate cancer utilizing [68Ga]Ga-PSMA-11 PET/MRI. Insights into Imaging. 15(1). 299–299. 3 indexed citations
3.
Hantusch, Brigitte, et al.. (2024). Targeting Androgen, Thyroid Hormone, and Vitamin A and D Receptors to Treat Prostate Cancer. International Journal of Molecular Sciences. 25(17). 9245–9245. 3 indexed citations
4.
Heiduschka, Gregor, et al.. (2024). Lymphocyte-to-Monocyte Ratio Might Serve as a Prognostic Marker in Young Patients with Tongue Squamous Cell Carcinoma. Journal of Personalized Medicine. 14(2). 159–159. 1 indexed citations
5.
Jank, Bernhard J., et al.. (2023). High USP4 mRNA is associated with an HPV-positive status in head and neck squamous cell carcinoma patients. Journal of Cancer Research and Clinical Oncology. 149(12). 10675–10683. 1 indexed citations
6.
Pichler, Alexander, Christoph Kornauth, Lukas Kazianka, et al.. (2023). Distinct Subtypes of Chemotherapy-Resistant Systemic ALK-Positive Anaplastic Large Cell Lymphoma Demonstrate Long-Term Complete Remissions to Imatinib. Blood. 142(Supplement 1). 1691–1691. 1 indexed citations
7.
Brkic, Faris F., et al.. (2023). β-CATENIN is a positive prognostic marker for HPV-positive head and neck squamous cell carcinoma. Journal of Cancer Research and Clinical Oncology. 149(10). 7743–7750.
8.
Moser, Doris, Katy Schmidt, Petra Pjevac, et al.. (2023). Defects in microvillus crosslinking sensitize to colitis and inflammatory bowel disease. EMBO Reports. 24(10). e57084–e57084. 11 indexed citations
9.
Tobias, Joshua, Sandra Högler, Yee Chao, et al.. (2023). Preclinical and Clinical Observations Implying Combination Therapy to Enhance the Efficacy of the Her-2/neu B-Cell Peptide-Based Vaccine HER-Vaxx and to Prevent Immune Evasion. International Journal of Molecular Sciences. 25(1). 287–287. 1 indexed citations
10.
Brkic, Faris F., et al.. (2022). Targeting Wnt/Beta-Catenin Signaling in HPV-Positive Head and Neck Squamous Cell Carcinoma. Pharmaceuticals. 15(3). 378–378. 9 indexed citations
11.
Pecoraro, Matteo, Heidi A. Neubauer, Karolína Trachtová, et al.. (2021). Proteomic Analysis Identifies NDUFS1 and ATP5O as Novel Markers for Survival Outcome in Prostate Cancer. Cancers. 13(23). 6036–6036. 4 indexed citations
12.
Jank, Bernhard J., et al.. (2021). Prognostic Relevance of Thyroid-Hormone-Associated Proteins in Adenoid Cystic Carcinoma of the Head and Neck. Journal of Personalized Medicine. 11(12). 1352–1352. 3 indexed citations
13.
Rossi, Guendalina, et al.. (2020). Exocyst structural changes associated with activation of tethering downstream of Rho/Cdc42 GTPases. The Journal of Cell Biology. 219(2). 28 indexed citations
14.
Kadletz, Lorenz, Faris F. Brkic, Bernhard J. Jank, et al.. (2019). AF1q Expression Associates with CD44 and STAT3 and Impairs Overall Survival in Adenoid Cystic Carcinoma of the Head and Neck. Pathology & Oncology Research. 26(2). 1287–1292. 3 indexed citations
15.
Kadletz, Lorenz, Gregor Heiduschka, Axel Wolf, et al.. (2017). Effect of postoperative radiotherapy in pT1pN1cM0 and pT2p/cN0cM0 oropharyngeal squamous cell carcinoma. The Laryngoscope. 128(5). 1075–1082. 1 indexed citations
16.
Ebner, Florian, Vitaly Sedlyarov, Saren Tasciyan, et al.. (2017). The RNA-binding protein tristetraprolin schedules apoptosis of pathogen-engaged neutrophils during bacterial infection. Journal of Clinical Investigation. 127(6). 2051–2065. 27 indexed citations
17.
Russi, Silvia, Ana González, Lukas Kenner, et al.. (2016). Conformational variation of proteins at room temperature is not dominated by radiation damage. Journal of Synchrotron Radiation. 24(1). 73–82. 47 indexed citations
18.
Schwab, Clarissa, David Berry, Isabella Rauch, et al.. (2014). Longitudinal study of murine microbiota activity and interactions with the host during acute inflammation and recovery. The ISME Journal. 8(5). 1101–1114. 156 indexed citations
19.
Vesely, Paul, Brigitte Hantusch, Michaela Schlederer, et al.. (2009). Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signaling. Proceedings of the National Academy of Sciences. 106(48). 20423–20428. 57 indexed citations
20.
Puhr, Martin, Frédéric R. Santer, Hannes Neuwirt, et al.. (2009). Down-regulation of Suppressor of Cytokine Signaling-3 Causes Prostate Cancer Cell Death through Activation of the Extrinsic and Intrinsic Apoptosis Pathways. Cancer Research. 69(18). 7375–7384. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026